Patents by Inventor Christina Nord
Christina Nord has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11981755Abstract: The present invention relates to novel compounds, which presents a peptide structure and an unexpected antibacterial effect even against certain multiresistant bacteria. The compounds may be cyclic peptides, sometimes depsipeptides, or non-ring-closed peptides, as defined by Formula (I). Further, the invention relates to the medical use of the herein claimed compounds, a method for the production of the compounds as well as a method of treatment including the compounds. In addition, the invention relates to a pharmaceutical preparation comprising one or more of the herein described and claimed compounds combined with suitable carrier(s) and/or adjuvant(s). Finally, the invention is the use of one or more of the claimed compounds in a method for decolonization of a surface of Gram-positive and/or Gram-negative bacteria.Type: GrantFiled: August 27, 2019Date of Patent: May 14, 2024Assignee: ULTUPHARMA ABInventors: Bo Öberg, Anders Broberg, Bengt Guss, Jolanta Levenfors, Joakim Bjerketorp, Christina Nord
-
Publication number: 20210269483Abstract: The present invention relates to novel compounds, which presents a peptide structure and an unexpected antibacterial effect even against certain multiresistant bacteria. The compounds may becyclic peptides, sometimes depsipeptides, ornon-ring-closed peptides, asdefined by Formula (I). Further, the invention relates to the medical use of the herein claimed compounds, a method for the production of the compounds as well as a method of treatment including the compounds. In addition, the invention relates to a pharmaceutical preparation comprising one or more of the herein described and claimed compounds combined with suitable carrier(s) and/or adjuvant(s). Finally, the invention is the use of one or more of the claimed compounds in a method for decolonization of a surface of Gram-positive and/or Gram-negative bacteria.Type: ApplicationFiled: August 27, 2019Publication date: September 2, 2021Applicant: ULTUPHARMA ABInventors: Bo ÖBERG, Anders BROBERG, Bengt GUSS, Jolanta LEVENFORS, Joakim BJERKETORP, Christina NORD
-
Patent number: 10828317Abstract: The present invention relates to a composition comprising a first compound which is a nucleoside analogue capable of inhibiting a bacterial colonisation or infection of a subject; a second compound which is capable of decreasing mitochondrial toxicity of said nucleoside analogue and surprisingly enhance the antibacterial effect of the combination; and a third compound capable of decreasing the concentration in bacteria of nucleosides and/or nucleotides known to compete with nucleoside analogues. The first compound may be AZT, FdUrd, 5-fluorouracil, BrdUrd, IdUrd, didanosine or gemcitabine; the second compound may be uridine or a uridine-comprising compound; and the third compound may be iclaprim; trimethoprim; or a compound comprising trimethoprim, such as trimethoprim-sulfa.Type: GrantFiled: May 24, 2018Date of Patent: November 10, 2020Assignee: Ultupharma ABInventors: Bo Öberg, Anders Broberg, Bengt Guss, Jolanta Levenfors, Joakim Bjerketorp, Christina Nord
-
Patent number: 10828316Abstract: The present invention relates to a composition comprising a first compound which is a nucleoside analogue capable of inhibiting a bacterial colonisation or infection of a subject; a second compound which is capable of decreasing mitochondrial toxicity of said nucleoside analogue and surprisingly enhance the antibacterial effect of the combination; and a third compound capable of decreasing the concentration in bacteria of nucleosides and/or nucleotides known to compete with nucleoside analogues. The first compound may be AZT, FdUrd, 5-fluorouracil, BrdUrd, IdUrd, didanosine or gemcitabine; the second compound may be uridine or a uridine-comprising compound; and the third compound may be trimethoprim or a compound comprising trimethoprim, such as trimethoprim-sulfa.Type: GrantFiled: January 27, 2017Date of Patent: November 10, 2020Assignee: ULTUPHARMA ABInventors: Bo Öberg, Anders Broberg, Bengt Guss, Jolanta Levenfors, Joakim Bjerketorp, Christina Nord
-
Publication number: 20180325934Abstract: The present invention relates to a composition comprising a first compound which is a nucleoside analogue capable of inhibiting a bacterial colonisation or infection of a subject; a second compound which is capable of decreasing mitochondrial toxicity of said nucleoside analogue and surprisingly enhance the antibacterial effect of the combination; and a third compound capable of decreasing the concentration in bacteria of nucleosides and/or nucleotides known to compete with nucleoside analogues. The first compound may be AZT, FdUrd, 5-fluorouracil, BrdUrd, IdUrd, didanosine or gemcitabine; the second compound may be uridine or a uridine-comprising compound; and the third compound may be trimethoprim or a compound comprising trimethoprim, such as trimethoprim-sulfa.Type: ApplicationFiled: January 27, 2017Publication date: November 15, 2018Applicant: ULTUPHARMA ABInventors: Bo ÖBERG, Anders BROBERG, Bengt GUSS, Jolanta LEVENFORS, Joakim BJERKETORP, Christina NORD
-
Publication number: 20180280417Abstract: The present invention relates to a composition comprising a first compound which is a nucleoside analogue capable of inhibiting a bacterial colonisation or infection of a subject; a second compound which is capable of decreasing mitochondrial toxicity of said nucleoside analogue and surprisingly enhance the antibacterial effect of the combination; and a third compound capable of decreasing the concentration in bacteria of nucleosides and/or nucleotides known to compete with nucleoside analogues. The first compound may be AZT, FdUrd, 5-fluorouracil, BrdUrd, IdUrd, didanosine or gemcitabine; the second compound may be uridine or a uridine-comprising compound; and the third compound may be iclaprim; trimethoprim; or a compound comprising trimethoprim, such as trimethoprim-sulfa.Type: ApplicationFiled: May 24, 2018Publication date: October 4, 2018Applicant: ULTUPHARMA ABInventors: Bo ÖBERG, Anders BROBERG, Bengt GUSS, Jolanta LEVENFORS, Joakim BJERKETORP, Christina NORD
-
Patent number: 7347099Abstract: An improved pressure transducer is disclosed. The transducer includes a connector, an enclosure, a sensor portion, and an external heater disposed to heat the sensor portion. In some aspects, the sensor portion includes a sensor constructed from a brittle material and does not employ any fill fluid within the sensor. In another aspect, the invention includes a kit that adapts non-heated high purity vacuum transducers for heated use. The kit includes a connector portion and a heater portion that is coupled to the connector portion. The connector portion may also include one or more indicators.Type: GrantFiled: July 16, 2004Date of Patent: March 25, 2008Assignee: Rosemount Inc.Inventors: Wesley E. Sund, Christina A. Nord, Fred C. Sittler, John McIntire
-
Publication number: 20060010983Abstract: An improved pressure transducer is disclosed. The transducer includes a connector, an enclosure, a sensor portion, and an external heater disposed to heat the sensor portion. In some aspects, the sensor portion includes a sensor constructed from a brittle material and does not employ any fill fluid within the sensor. In another aspect, the invention includes a kit that adapts non-heated high purity vacuum transducers for heated use. The kit includes a connector portion and a heater portion that is coupled to the connector portion. The connector portion may also include one or more indicators.Type: ApplicationFiled: July 16, 2004Publication date: January 19, 2006Applicant: Rosemount Inc.Inventors: Wesley Sund, Christina Nord, Fred Sittler, John McIntire
-
Patent number: 6848316Abstract: A pressure sensor assembly includes an elongate pressure sensor mounted to a sensor mounting block. A protective element covers the elongate pressure sensor to prevent the pressure sensor from contacting process fluid.Type: GrantFiled: May 8, 2002Date of Patent: February 1, 2005Assignee: Rosemount Inc.Inventors: Fred C. Sittler, Christina A. Nord, Mark G. Romo
-
Patent number: 6662662Abstract: A pressure transmitter with a fluid isolator that includes a sensor tube and a fill tube that have “D” shaped ends that connect together in a port internal to the transmitter. The shaped ends can be brazed into the port for sealing. Fitting both the sensor tube and the fill tube in the same port provides a low cost isolator with reduced isolator liquid volume. The fluid isolator has an isolator diaphragm with a central diaphragm region overlying a central backing plate that includes a annular groove. The annular groove avoids slow response of the isolator after an overpressure condition.Type: GrantFiled: May 4, 2000Date of Patent: December 16, 2003Assignee: Rosemount, Inc.Inventors: Christina A. Nord, David A. Horky, Kenneth G. Guttsen, Thomas E. Johnson, Matthew G. Sherin, Kevin P. Szafranski, William J. Ballot, Renae M. Patrick, Donald E. Harasyn, Ryan R. Eidenschink, Todd W. Schansberg, Mark G. Romo, Steven M. Behm, Bennett L. Louwagie, Robert C. Hedtke, Stanley E. Rud, Jr., Jeffrey C. Brekken
-
Publication number: 20030209080Abstract: A pressure sensor assembly includes an elongate pressure sensor mounted to a sensor mounting block. A protective element covers the elongate pressure sensor to prevent the pressure sensor from contacting process fluid.Type: ApplicationFiled: May 8, 2002Publication date: November 13, 2003Inventors: Fred C. Sittler, Christina A. Nord, Mark G. Romo